johnson & johnson news

Johnson & Johnson posts Q3 beat; lowers earnings guidance amid M&A impact

Johnson & Johnson (NYSE:JNJ) lowered its full-year earnings outlook on Tuesday despite posting better-than-expected financials for Q3 2024, driven mainly by its pharma unit even as its MedTech division fell short of forecasts.

MarketWatch on MSN · 3h

Johnson & Johnson stock rises on Q3 sales beat and guidance raise

Johnson & Johnson shares rose 0.7% in premarket trades Tuesday after the drugmaker reported better-than-expected third-quarter sales and raised full-year revenue guidance.

SFGate · 6h

Johnson & Johnson: Q3 Earnings Snapshot

The average estimate of seven analysts surveyed by Zacks Investment Research was for earnings of $2.22 per share. The world's biggest maker of health care products posted revenue of $22.47 billion in the period,

Bill Belichick has harsh words for Jets owner Woody Johnson

Bleacher Report · 4h

Bill Belichick Rips Jets Owner Woody Johnson for Robert Saleh Firing on 'Manningcast'

Former New England Patriots head coach Bill Belichick joined the mass of critics who believe New York Jets owner Woody Johnson made a premature decision

The New York Times · 11h

Bill Belichick criticizes Jets’ firing of Robert Saleh: ‘The owner being the owner — just ready, fire, aim’

Bill Belichick criticized the New York Jets’ decision to fire coach Robert Saleh on Monday, describing the move as a “little early” and taking a dig at team owner Woody Johnson. The comments add to a quarter-century rift between the longtime New England Patriots coach and the rival Jets,

USA TODAY Sports on MSN · 14h

Bill Belichick has harsh words for Jets owner Woody Johnson during 'Monday Night Football'

On the "ManningCast," former Patriots head coach Bill Belichick shared some criticism of Jets owner Woody Johnson after he fired Robert Saleh.

2hon MSN

Johnson & Johnson Posts Weaker-Than-Expected Profit on Billions in Legal Costs

Johnson & Johnson's third-quarter net income fell short of expectations as the company reported billions of dollars in ...

FiercePharma1h

Johnson & Johnson eases initial Stelara blows with strong Darzalex, Carvykti growth

Johnson & Johnson's immunology superstar Stelara and oncology blockbuster Darzalex have long been among the company's top ...

Marketplace3h

Nobel laureate Simon Johnson on AI and the workforce

MIT's Simon Johnson is one of this year's Nobel Memorial Prize in Economic Sciences. HIs work focuses on how institutions ...

Kent Johnson was a Johnny Gaudreau fan before teammate: 'He was a big inspiration'

At age 12, the Blue Jackets' future fifth overall pick was a scrawny forward who saw himself in a small, dynamic rookie for ...

8mon MSN

Kansas State's Avery Johnson Shows Toughness By Playing Through Injury

K-State sophomore quarterback Avery Johnson went down with an injury during the third quarter against Colorado. The score ...

12hon MSN

Dwayne Johnson’s ‘Red One’ Sets China Theatrical Release (EXCLUSIVE)

The Dwayne Johnson-starring Christmas-themed comedy adventure film “Red One” is set for a theatrical release in mainland ...

20hon MSN

Where Speaker Johnson sees the GOP's path to victory: From the Politics Desk

At rallies, Johnson and former President Donald Trump have blamed Vice President Kamala Harris for the high cost of goods and ...

Could Termarr Johnson Be Pirates' Shortstop of the Future?

Few things are as important for a team as having a solid and reliable shortstop and figuring out who that player will be for ...

Johnson & Johnson's Q3 Earnings: Revenue And EPS Beat On Strong Cancer Drug Sales, Revises Annual Outlook To Reflect V-Wave Acquisition

Johnson & Johnson reported third-quarter earnings with adjusted EPS of $2.42, surpassing expectations. Sales rose 5.2% to $22.47B. J&J updated its 2024 adjusted EPS guidance, lowering it slightly to ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results

Related topics